Skip to main content
. 2021 Jan 18;32(4):296–305. doi: 10.1097/WNR.0000000000001596

Table 1.

Effect of fisetin on SCI-induced alteration in body weight, food intake, water intake, urine output and urine protein level

Treatment Normal Sham SCI Control Methylprednisolone (30) Fisetin (10) Fisetin (20) Fisetin (40)
Body weight (g) 227.20 ± 2.37 230.20 ± 0.95 169.00 ± 1.93#,& 219.20 ± 1.85*,$ 176.80 ± 2.01 189.70 ± 0.92*,$ 211.50 ± 1.75*,$
Food intake (g) 24.33 ± 0.49 21.33 ± 0.76 10.50 ± 0.62#,& 20.00 ± 0.58*,$ 13.67 ± 0.92 16.50 ± 0.67*,$ 17.83 ± 0.79*,$
Water intake (mL) 40.67 ± 1.75 37.67 ± 0.71 23.00 ± 1.21#,& 35.50 ± 1.50*,$ 23.83 ± 1.35 29.67 ± 1.56*,$ 34.33 ± 1.54*,$
Volume of urine expressed in 24 h (ml) 1.17 ± 0.17 1.67 ± 0.21 5.17 ± 0.17#,& 2.33 ± 0.21*,$ 5.00 ± 0.26 3.33 ± 0.21*,$ 2.67 ± 0.21*,$
Urine protein (mg/ml) 1.66 ± 0.18 2.38 ± 0.16 6.97 ± 0.26#,& 3.31 ± 0.16*,$ 6.63 ± 0.20 4.87 ± 0.12*,$ 3.62 ± 0.14*,$

Data are expressed as mean ± SEM (n = 6) and one-way ANOVA followed by Tukey’s multiple range test.

ANOVA, analysis of variance; SCI, spinal cord injury.

#P < 0.05 as compared with sham group.

&P < 0.05 as compared with normal.

*p < 0.05 as compared with the SCI control group.

$P < 0.05 as compared with one another.